Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maintenance With Tacrolimus”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Post-approval studies (Phase 4)Looking for participantsNCT06751992
What this trial is testing

Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients

Who this might be right for
Kidney Transplant RecipientsOld Age
Massachusetts General Hospital 92
Post-approval studies (Phase 4)Study completedNCT00171717
What this trial is testing

Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant

Who this might be right for
Maintenance Liver Transplant Patients With New Onset Diabetes
Novartis 39
Post-approval studies (Phase 4)Ended earlyNCT00150085
What this trial is testing

Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion

Who this might be right for
Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant Recipients
Novartis 50
Post-approval studies (Phase 4)Ended earlyNCT00596947
What this trial is testing

Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant

Who this might be right for
Transplants and Implants
University of Pennsylvania 18
Testing effectiveness (Phase 2)Study completedNCT00175253
What this trial is testing

Alemtuzumab Induction in Islet Transplantation

Who this might be right for
Type 1 Diabetes
University of Alberta 12
Post-approval studies (Phase 4)Study completedNCT00807144
What this trial is testing

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation

Who this might be right for
End-stage Renal FailureGraft Rejection
Imperial College Healthcare NHS Trust 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT03114865
What this trial is testing

Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Who this might be right for
Acute Lymphoblastic LeukemiaB-cell Non Hodgkin LymphomaPre B-Cell Acute Lymphoblastic Leukaemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Large-scale testing (Phase 3)Study completedNCT00284934
What this trial is testing

Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients

Who this might be right for
Kidney Diseases
Novartis 94
Post-approval studies (Phase 4)UnknownNCT04224350
What this trial is testing

Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)

Who this might be right for
Kidney Transplant
Chong Kun Dang Pharmaceutical 184
Post-approval studies (Phase 4)UnknownNCT04069065
What this trial is testing

Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)

Who this might be right for
Liver Transplant
Chong Kun Dang Pharmaceutical 146
Not applicableStudy completedNCT01653847
What this trial is testing

Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens

Who this might be right for
End Stage Renal Failure With Renal Transplant
Northwestern University 88
Post-approval studies (Phase 4)Study completedNCT02432833
What this trial is testing

Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients

Who this might be right for
End Stage Renal Disease
Chiesi Farmaceutici S.p.A. 428
Post-approval studies (Phase 4)Study completedNCT00650468
What this trial is testing

Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

Who this might be right for
Renal Transplantation
Astellas Pharma Inc 397
Not applicableStudy completedNCT02160054
What this trial is testing

Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)

Who this might be right for
the Maintenance Phase After Kidney Transplantation
Astellas Pharma Inc 289
Large-scale testing (Phase 3)WithdrawnNCT03596970
What this trial is testing

Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT00938860
What this trial is testing

Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C

Who this might be right for
Hepatitis CLiver Transplantation
Novartis Pharmaceuticals 92
Post-approval studies (Phase 4)Study completedNCT01172418
What this trial is testing

Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols

Who this might be right for
Transplant; Failure, Kidney
University of Miami 200
Testing effectiveness (Phase 2)Study completedNCT00089947
What this trial is testing

Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection

Who this might be right for
Renal TransplantationGraft Rejection
Genzyme, a Sanofi Company 150
Post-approval studies (Phase 4)WithdrawnNCT02062892
What this trial is testing

Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
University of Colorado, Denver
Large-scale testing (Phase 3)Ended earlyNCT01841008
What this trial is testing

Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control

Who this might be right for
Pigmentation DisordersVitiligo
Centre Hospitalier Universitaire de Nice 35
Next Page